2025-11-04 20:36:33
Latest Post
Indian Metals and Ferro Alloys Ltd Q2FY26 consolidated net profit increases QoQ to Rs. 97.48 crores
Krebs Biochemicals and Industries Ltd Q2 FY2026 loss at Rs. 6.14 crores
Mahindra and Mahindra Ltd reports consolidated Q2FY26 PAT of Rs. 3673.32 crores
Adani Ports and Special Economic Zone Ltd consolidated PAT for Q2FY26 at Rs. 3109.05 crores
Allcargo Terminals Ltd Q2FY26 consolidated profit up at Rs. 11.30 crores
Stock Report
Neuland Laboratories Ltd Q4 FY2024 consolidated PAT falls to Rs. 67.56 crores
Posted On : 2024-05-11 09:44:38( TIMEZONE : IST )
Neuland Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 390.3667 crores during the period ended March 31, 2024 as compared to Rs. 394.9289 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 67.5619 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 81.3902 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 52.66 for the period ended March 31, 2024 as compared to Rs. 63.44 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹390.3667 crs | ₹394.9289 crs |  -1.16% |
| Net Profit | ₹67.5619 crs | ₹81.3902 crs | -16.99% |
| EPS | ₹52.66 | ₹63.44 | -16.99% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs.390.3667 crores during the period ended March 31, 2024 as compared to Rs.415.1368 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.67.5619 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.84.5439 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.52.66 for the period ended March 31, 2024 as compared to Rs.65.90 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹390.3667 crs | ₹415.1368 crs | -5.97% |
| Net Profit | ₹67.5619 crs | ₹84.5439 crs | -20.09% |
| EPS | ₹52.66 | ₹65.90 | -20.09% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.1571.1248 crores during the Financial Year ended March 31, 2024 as compared to Rs.1200.9462 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.300.0789 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.163.5176 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.233.89 for the Financial Year ended March 31, 2024 as compared to Rs.127.45 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹1571.1248 crs | ₹1200.9462 crs |  30.82% |
| Net Profit | ₹300.0789 crs | ₹163.5176 crs | 83.51% |
| EPS | ₹233.89 | ₹127.45 | 83.52% |
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 7447.45 as compared to the previous close of Rs. 7356.15. The total number of shares traded during the day was 1147 in over 428 trades.
The stock hit an intraday high of Rs. 7476.65 and intraday low of 7263.05. The net turnover during the day was Rs. 8519465.00.
